A new report by XploreMR studies the growth drivers, trends, restraints, and highlights of the global vascular access catheters market. Presenting exclusive insights into the market from 2017 to 2027, the report projects that the market will witness notable growth during the forecast period. Vascular access catheters are devices used to introduce solutions and remove contaminants by directly being inserted into the veins. Vascular catheters are primarily used for diagnostic and therapeutic purposes, such as blood sampling, central venous pressure readings, administration of medication, fluids, total parenteral nutrition (TPN), and blood transfusions. The growth of the market is predominantly attributed to the rising incidence of chronic diseases, which require treatment through the vascular access. The high success rate of vascular access treatment in treating complications associated with critically ill patients and children is also complementing the rising rate of adoption in the medical landscape.

Rising Incidence of Chronic Diseases Nurtures Growth

There has been a sharp rise in the incidence of several chronic diseases, such as cancer, kidney failure, and cardiovascular diseases, among others. Such disease requires vascular access to treat the patients, and is expected to act as a significant growth driver to the vascular access catheters in the forthcoming years. Moreover, the disorders associated with chronic and non-communicable disease conditions, such as hypertension, diabetes, and obesity also create the necessity for vascular access catheters in several cases. Similarly, vascular access is considered the ideal methodology to treat patients undergoing dialysis treatment, with arteriovenous fistula being the most sought-out therapy. Vascular access catheters are also highly used in cases of chemotherapy and end-stage renal disease (ESRD). Furthermore, the increasing incidence of lifestyle disorders is also surging the demand for intravenous antibiotic treatment, long intravenous nutritional support, and to draw blood samples. An increasing number of diseases in both developed and developing economies, will continue to channel revenue through the forecast period.

Possibility of Infections to Impede Adoption Rates

Possible complications associated with central venous catheterization procedures, such as bleeding, damage to blood vessels, arterial puncture, hematoma, and pneumothorax are likely to hinder the growth of the market to a certain extent. Furthermore, there is a likelihood of complications such as infections at the insertion site of the catheter, contamination of catheters, and increasing awareness regarding the risk of infection is creating reluctance among patients to opt for catheterization. The aforementioned factors can pose a challenge to the swift growth of the market.